Clinical and echocardiographic characteristics of the patients
| Clincal and echocardiographic characteristics | Mean ± SD or N (%) or median (IQR) |
|---|---|
| Age (years) | 65.4 ± 10.2 |
| Sex, N (%) | |
| Male | 180 (71.7%) |
| Female | 72 (28.6%) |
| Body surface area (m2) | 1.94 |
| Hypertension, N (%) | 218 (86.5%) |
| Diabetes, N (%) | 53 (21.1%) |
| B-blockers, N (%) | 172 (68.3%) |
| Ace-inhibitors/Sartans, N (%) | 201 (79.8%) |
| History of myocardial infarction, N (%) | 118 (46.8%) |
| Previous PCI/CABG, N (%) | 109 (43.3%) |
| B-lines at rest, median (IQR) | 0.4 (0–30) |
| B-lines at rest (≥ 2), N (%) | 19 (7.5%) |
| B-lines at peak, median (IQR) | 0.7 (0–30) |
| B-lines at peak (≥ 2), N (%) | 29 (11.5%) |
| LAVI at rest (ml/m2) | 26.5 ± 12.5 |
| LAVI at rest ≥ 34 ml/m2, N (%) | 39 (15.5%) |
| LAVI at peak (ml/m2) | 24.2 ± 12.1 |
| LAVI at peak ≥ 34 ml/m2, N (%) | 33 (13.1%) |
| LASr at rest (%) | 33.0 ± 8.2 |
| LASr at rest ≤ 24%, N (%) | 37 (14.7%) |
| LASr at peak (%) | 38.0 ± 10.1 |
| LASr at peak ≤ 24%, N (%) | 23 (14.7%) |
| Ejection fraction at rest (%) | 59.3 ± 7.2 |
| Ejection fraction at peak (%) | 73.0 ± 7.8 |
PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft